share_log

Viatris Analyst Ratings

Benzinga ·  Oct 23, 2023 19:20
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/23/2023 -0.33% B of A Securities → $9 Downgrades Neutral → Underperform
06/23/2023 21.82% Barclays → $11 Downgrades Equal-Weight → Underweight
04/25/2023 21.82% Barclays $16 → $11 Downgrades Overweight → Equal-Weight
04/24/2023 21.82% Barclays → $11 Downgrades Overweight → Equal-Weight
02/28/2023 77.19% Barclays $15 → $16 Maintains Overweight
02/17/2023 55.04% BMO Capital $16 → $14 Downgrades Outperform → Market Perform
02/01/2023 66.11% Barclays $16 → $15 Maintains Overweight
01/27/2023 66.11% Jefferies $13 → $15 Upgrades Hold → Buy
11/15/2022 55.04% JP Morgan $13 → $14 Maintains Neutral
11/10/2022 32.89% UBS $9 → $12 Upgrades Sell → Neutral
11/08/2022 10.74% Piper Sandler → $10 Upgrades Underweight → Neutral
10/25/2022 77.19% Barclays $21 → $16 Maintains Overweight
10/21/2022 21.82% Jefferies → $11 Initiates Coverage On → Hold
08/09/2022 77.19% BMO Capital $19 → $16 Maintains Outperform
06/14/2022 -0.33% UBS → $9 Initiates Coverage On → Sell
05/12/2022 21.82% Goldman Sachs $10 → $11 Maintains Neutral
05/10/2022 10.74% Piper Sandler → $10 Downgrades Neutral → Underweight
03/16/2022 10.74% Piper Sandler $17 → $10 Maintains Neutral
03/10/2022 21.82% Citigroup $16 → $11 Maintains Neutral
03/01/2022 43.96% B of A Securities $21 → $13 Downgrades Buy → Neutral
03/01/2022 Raymond James Downgrades Outperform → Market Perform
06/15/2021 77.19% Citigroup → $16 Initiates Coverage On → Neutral
03/10/2021 77.19% Morgan Stanley $18 → $16 Maintains Equal-Weight
03/08/2021 66.11% Goldman Sachs $20 → $15 Downgrades Buy → Neutral
03/02/2021 99.34% JP Morgan → $18 Downgrades Overweight → Neutral
02/23/2021 110.41% Raymond James $23 → $19 Maintains Outperform
01/25/2021 154.71% Raymond James $27 → $23 Maintains Outperform
01/05/2021 Argus Research Initiates Coverage On → Hold
12/14/2020 132.56% Bernstein → $21 Initiates Coverage On → Market Perform
11/19/2020 143.63% Goldman Sachs → $22 Reinstates → Buy
11/18/2020 Edward Jones Initiates Coverage On → Sell

What is the target price for Viatris (VTRS)?

The latest price target for Viatris (NASDAQ: VTRS) was reported by B of A Securities on October 23, 2023. The analyst firm set a price target for $9.00 expecting VTRS to fall to within 12 months (a possible -0.33% downside). 12 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Viatris (VTRS)?

The latest analyst rating for Viatris (NASDAQ: VTRS) was provided by B of A Securities, and Viatris downgraded their underperform rating.

When is the next analyst rating going to be posted or updated for Viatris (VTRS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Viatris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Viatris was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.

Is the Analyst Rating Viatris (VTRS) correct?

While ratings are subjective and will change, the latest Viatris (VTRS) rating was a downgraded with a price target of $0.00 to $9.00. The current price Viatris (VTRS) is trading at is $9.03, which is out of the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment